ASSET | DATE | % RETURN |
---|---|---|
Plug Power (PLUG) | 11/1/2013 - 1/30/2014 | 420% |
Camtek (CAMT) | 11/1/2013 - 1/30/2014 | 186.27% |
Mr Cooper (COOP) | 11/1/2013 - 1/30/2014 | 129.36% |
Corcept Therapeutics (CORT) | 11/1/2013 - 1/30/2014 | 122.02% |
Arrowhead Pharmaceuticals (ARWR) | 11/1/2013 - 1/30/2014 | 119.2% |
ANI Pharmaceuticals (ANIP) | 11/1/2013 - 1/30/2014 | 103.66% |
Novavax (NVAX) | 11/1/2013 - 1/30/2014 | 95.13% |
Harrow Health (HROW) | 11/1/2013 - 1/30/2014 | 89.81% |
Frontline (FRO) | 11/1/2013 - 1/30/2014 | 87.01% |
AerCap (AER) | 11/1/2013 - 1/30/2014 | 86.31% |
Neurocrine Biosciences (NBIX) | 11/1/2013 - 1/30/2014 | 81.36% |
TKO (TKO) | 11/1/2013 - 1/30/2014 | 81.35% |
BioCryst Pharmaceuticals (BCRX) | 11/1/2013 - 1/30/2014 | 80.35% |
CMBTECH (CMBT) | 11/1/2013 - 1/30/2014 | 77.84% |
Avadel Pharmaceuticals (AVDL) | 11/1/2013 - 1/30/2014 | 73.56% |
Jazz Pharmaceuticals (JAZZ) | 11/1/2013 - 1/30/2014 | 72% |
TG Therapeutics (TGTX) | 11/1/2013 - 1/30/2014 | 71.03% |
Danaos (DAC) | 11/1/2013 - 1/30/2014 | 70.25% |
Incyte (INCY) | 11/1/2013 - 1/30/2014 | 70.21% |
MakeMyTrip (MMYT) | 11/1/2013 - 1/30/2014 | 66.36% |
DHT (DHT) | 11/1/2013 - 1/30/2014 | 63.91% |
Illumina (ILMN) | 11/1/2013 - 1/30/2014 | 61.34% |
Ambarella (AMBA) | 11/1/2013 - 1/30/2014 | 58.25% |
Travere Therapeutics (TVTX) | 11/1/2013 - 1/30/2014 | 57% |
Precigen (PGEN) | 11/1/2013 - 1/30/2014 | 54.81% |